Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Jul 31, 2019

SELL
$125.55 - $144.48 $72,693 - $83,653
-579 Closed
0 $0
Q4 2018

Jan 22, 2019

SELL
$115.94 - $166.74 $282,545 - $406,345
-2,437 Reduced 80.8%
579 $72,000
Q3 2018

Oct 15, 2018

SELL
$161.01 - $180.57 $322 - $361
-2 Reduced 0.07%
3,016 $507,000
Q2 2018

Jul 19, 2018

SELL
$146.33 - $183.18 $7,170 - $8,975
-49 Reduced 1.6%
3,018 $520,000
Q1 2018

Apr 13, 2018

BUY
$135.59 - $157.16 $135 - $157
1 Added 0.03%
3,067 $463,000
Q4 2017

Jan 17, 2018

SELL
$131.06 - $150.39 $6,421 - $7,369
-49 Reduced 1.57%
3,066 $412,000
Q3 2017

Oct 13, 2017

BUY
$142.62 - $155.6 $444,261 - $484,694
3,115
3,115 $456,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $6.8B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Somerset Trust CO Portfolio

Follow Somerset Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Somerset Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Somerset Trust CO with notifications on news.